Chair of the Department of Speech and Hearing Sciences
Dr. Ernest J. Moore is the Chair of the Department of Speech and Hearing Sciences, University of North Texas. He earned a B.S. in Speech-Language Pathology and Audiology at Tennessee A. & I. State University (Nashville), a M.A. in Audiology from Northern Illinois University (DeKalb), and a Ph.D. in Communicative Disorders, with a specialization in Experimental Audiology, from The University of Wisconsin (Madison).
Prof. Moore is a member of several scholarly, scientific, and professional societies, including the American Association for the Advancement of Science, the Association for Research in Otolaryngology, the Society of Neuroscience, the National Black Association of Speech, Language and Hearing, and the International Collegium of Rehabilitative Audiology, of which he is a charter member. Dr. Moore has received numerous awards, fellowships, and grants, including those from the National Institutes of Health, Deafness Research Foundation, the National Science Foundation, and the Montel Williams MS Foundation.
Dr. Moore comes to UNT from Northwestern University in Chicago, where he held an appointment of Research Professor and Knowles Scholar in the Department of Molecular Pharmacology and Biological Chemistry/Center for Drug Discovery and Chemical Biology in the Feinberg School of Medicine. He has also taught at Emerson College, Memphis State University, Howard University, and Michigan State University. He has authored many written works and peer-reviewed publications not only as an individual, but also in collaboration with other scholars, his graduate and undergraduate students. Dr. Moore's current research interest lies in the investigation of molecular ion channel activity that might underlie tinnitus. He has submitted an IRB application to treat patients suffering from tinnitus with already FDA-approved drugs. A scientific article was published in an international journal in September 2011.
Wu C, Gopal K, Gross GW, Lukas TJ, Moore EJ. An in vitro model for testing drugs to treat tinnitus. Eur J Pharmacol. 2011 Sep 30; 667(1-3): 188-94.